Manage RA with TACOTINIB ER 11: 11mg Tofacitinib Extended Release

TACOTINIB ER 11

Tofacitinib Extended Release 11 mg

TACOTINIB ER 11, containing Tofacitinib Extended Release 11 mg, is a groundbreaking medication used to manage autoimmune diseases such as rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. This extended-release formulation offers the convenience of once-daily dosing while providing consistent therapeutic effects throughout the day.

Understanding Tofacitinib :

Mechanism of Action:

• Tofacitinib is a Janus kinase (JAK) inhibitor that works by interfering with the signaling pathways inside cells that lead to inflammation and immune system activation.
• By inhibiting JAK enzymes, Tofacitinib helps reduce inflammation and halt the progression of autoimmune diseases.

Therapeutic Uses:

• Rheumatoid Arthritis: Effective in reducing symptoms such as joint pain, swelling, and stiffness.
• Psoriatic Arthritis: Helps alleviate joint and skin symptoms associated with psoriatic arthritis.
• Ulcerative Colitis: Used to induce and maintain remission in patients with moderate to severe ulcerative colitis.

Benefits of TACOTINIB ER 11 :

Consistent Symptom Control:

• Provides continuous relief from symptoms with once-daily dosing.
• Ensures steady blood levels of the medication, enhancing its effectiveness.

Improved Quality of Life:

• Reduces the frequency and severity of flare-ups.
• Improves physical function, allowing patients to engage in daily activities with less discomfort.

Convenient Dosage Form:

• Extended-release formulation simplifies the medication regimen.
• Enhances adherence to treatment by reducing the number of daily doses required.

Dosage and Administration :

Recommended Dosage:

• The standard dosage is one tablet of 11 mg taken once daily.
• It is crucial to follow the prescribed dosage and not to exceed the recommended amount.

How to Take:

• Swallow the tablet whole with a full glass of water.
• Can be taken with or without food, but consistency in timing is recommended for best results.

Potential Side Effects :

Common Side Effects:

• Headache
• Diarrhea
• Nasopharyngitis (common cold)

Less Common Side Effects:

• Elevated liver enzymes
• Increased cholesterol levels
• Anemia

Rare Side Effects:

• Serious infections
• Blood clots
• Gastrointestinal perforations

Precautions :

Who Should Avoid TACOTINIB ER 11:

• Individuals with severe liver disease.
• Patients with a history of blood clots or serious infections should use this medication with caution.

Consultation with Healthcare Provider:

• Always consult with your healthcare provider before starting TACOTINIB ER 11, especially if you have existing health conditions or are on other medications.
• Regular monitoring of blood counts and liver enzymes is recommended during treatment.

Conclusion :

TACOTINIB ER 11 offers an effective and convenient treatment option for managing autoimmune diseases. Its extended-release formulation provides consistent symptom control, improving the quality of life for patients. Proper use and adherence to the prescribed dosage can help manage these conditions effectively. Always consult with a healthcare provider to ensure that this medication is appropriate for your specific health needs.Steris Healthcare Pvt Ltd, established in February 2018 by seasoned professionals in the pharmaceutical sector, operates under the name Sterispharma. Headquartered in Navi Mumbai, the company is certified by WHO, GMP, and ISO. Sterispharma is dedicated to providing high-quality medications at affordable prices across India, adhering to stringent WHO guidelines. They offer an online pharmacy platform for easy medicine purchases and home delivery. The company's mission is to deliver a diverse range of healthcare products catering to the varied needs of the medical community. From advanced treatments and rare condition medications to essential health supplies, Sterispharma aims to meet the extensive demands of the healthcare industry. Their product range covers numerous health fields, including Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

For further information: 

EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

CALL/WHATSAPP: 7877551268, 7849827488

BUY NOW